Advertisement
Preface| Volume 1, ISSUE 1, P1-2, December 2022

Welcome to iGIE

      Abbreviation:

      ASGE (American Society for Gastrointestinal Endoscopy)
      On behalf of the American Society for Gastrointestinal Endoscopy (ASGE) leadership and our Associate Editors, I would like to welcome you to iGIE, the new open-access, online-only journal of the ASGE. Since announcing the launch of this new journal at Digestive Disease Week 2022, we have been asked countless times, “What does the ‘i’ stand for?” The best answer is that it stands for many things. The “i” can stand for “internet” as it does for the iPhone, iPad, iRobot, and similar products. Inasmuch as iGIE is an open-access internet-based journal that intends to provide a window to the future, that would make sense. However, the journal will also focus on the development of new procedures and technologies with a particular interest in preclinical, benchtop, ex vivo, and in vivo animal model studies, suggesting that the “i” could easily stand for “Innovation.” Additionally, the journal will emphasize translational work, pilot studies, first-in-human reports, and early clinical series, making “Investigation” a good alternative. As such, Innovations and Investigations will be the first 2 sections of the journal and will be consistently represented.
      For us to fully understand the development of new procedures and technologies and safely introduce them into clinical practice, it is important to consider all aspects of the process. This include regulatory concerns, manufacturing issues, clinical trial design, training, and other related aspects. Therefore, we will also include industry perspectives to shed light on these issues and provide a broader understanding of the field as it evolves. Furthermore, when we look at innovating the future, it is critical that we be informed by the past. Therefore, we will include a section on historical considerations to highlight important milestones and figures that have helped shape the current landscape and standards of practice. We will also include a section that distills important teaching points from live endoscopy case demonstrations to highlight how cutting edge technologies and procedures are being applied in everyday practice. This content falls under the “Insights” section.
      The journal will also explore “International” procedural trends and emerging literature. It will emphasize “Interdisciplinary” approaches to care, including hybrid procedures and material of interest to advanced practice providers, and it will also provide content on informatics and social media–related studies.
      As Gastrointestinal Endoscopy, the flagship journal of the ASGE, has grown to become one of the premier journals in GI it has needed to focus more on large clinical trials, meta-analyses, and guidelines. This success has made it more challenging for investigators to publish novel preclinical work and early clinical studies. These articles will find a home in iGIE. Steven Berlin Johnson, a contemporary author on the intersection of science, technology, and personal experience, wrote, “If you look at history, innovation doesn’t come just from giving people incentives; it comes from creating environments where their ideas can connect.” iGIE will provide that environment and foster the exchange of ideas to encourage the growth and development of our field.
      Finally, I would like to thank our inaugural editorial team and the ASGE and Elsevier staffs for their tireless work and creativity. They are passionate about providing our readers with the highest-quality thought-provoking content and will ensure the success of iGIE. With the strong following and brand of the ASGE and Gastrointestinal Endoscopy and the benefits of an open-access platform, we believe this new journal will have a broad readership and will serve the GI endoscopy community well. Welcome to iGIE!

      Disclosure

      Dr Thompson is a consultant for and the recipient of institutional research grants from Apollo Endosurgery; the recipient of institutional research grants from Aspire Bariatrics; a general partner in BlueFlame Healthcare Venture Fund; a consultant for and the recipient of institutional research grants from Boston Scientific; a consultant for Covidien/Medtronic; a founder of, consultant for, and board member of Enterasense Ltd; a founder of, board member of, and consultant for EnVision Endoscopy; the recipient of an institutional research grant from ERBE; a consultant for and advisory board member of Fractyl; a consultant for and recipient of an institutional research grant from FujiFilm; a consultant for and recipient of an institutional research grant from GI Dynamics; a founder of, board member of, and holder of ownership interest in GI Windows; a consultant for and recipient of an Institutional Research Grant from Lumendi; a consultant for and recipient of research equipment loan from Olympus/Spiration; and a consultant for, advisory board member of, and recipient of an institutional research grant from USGI Medical.
      Christopher C. Thompson, MD, MSC, FASGE
      Editor-in-Chief